Description
A NSAID that selectively inhibits COX-2 over COX-1 (IC50s = 0.018 and >15 µM, respectively, for production of PGE2 in CHO cells expressing the recombinant human enzymes); inhibits carrageenan-induced paw edema and hyperalgesia (ID50s = 1.5 and 1.0 mg/kg, respectively), LPS-induced pyresis (ID50 = 0.24 mg/kg), and M. butyricum-induced arthritis (ID50 = 0.74 mg/kg per day) in rats
Formal name: 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone
Synonyms: MK-966
Molecular weight: 314.4
CAS: 162011-90-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Neuroscience|Pain Research